Neurology · 2013 · 220 citations · 37 references
MedicineNeurologyNeuroscienceDementiaMovement DisordersNeurodegenerationGait DisordersGait EvaluationGait ImpairmentNeurodegenerative DiseasesParkinson DiseaseParkinsonian DisordersAge-related Gait ChangesCholinergic BiomarkersCholinergic Dysfunction In NeurodegenerationCognitive Gait DysfunctionCross-sectional Correlation StudyDopamine-related Movement DisordersGait Speed MeasurementNeurophysiology Of Parkinson's Disease
OBJECTIVE: We investigated dopaminergic and cholinergic correlates of gait speed in Parkinson disease (PD) and non-PD control subjects to test the hypothesis that gait dysfunction in PD may result from multisystem degeneration. METHODS: This was a cross-sectional study. Subjects with PD but without dementia (n = 125, age 65.6 ± 7.3 years) and elderly subjects without PD (n = 32, age 66.0 ± 10.6 years) underwent [¹¹C]dihydrotetrabenazine dopaminergic and [(11)C]methyl-4-piperidinyl propionate acetylcholinesterase PET imaging, and cognitive and clinical testing, including an 8.5-m walk in the dopaminergic "off" state. The fifth percentile of cortical cholinergic activity in the elderly without PD was used to define normal-range activity in the subjects with PD. RESULTS: Normal-range cortical cholinergic activity was present in 87 subjects with PD (69.6%). Analysis of covariance using gait speed as the dependent variable demonstrated a significant model (F = 6.70, p < 0.0001) with a significant group effect (F = 3.36, p = 0.037) and significant slower gait speed in the low cholinergic PD subgroup (0.97 ± 0.22 m/s) with no significant difference between the normal-range cholinergic PD subgroup (1.12 ± 0.20 m/s) and control subjects (1.17 ± 0.18 m/s). Covariate effects were significant for cognition (F = 6.58, p = 0.011), but not for striatal dopaminergic innervation, sex, or age. CONCLUSION: Comorbid cortical cholinergic denervation is a more robust marker of slowing of gait in PD than nigrostriatal denervation alone. Gait speed is not significantly slower than normal in subjects with PD with relatively isolated nigrostriatal denervation.
37
Christopher G. Goetz, Werner Poewe, Olivier Rascol et al. · Movement Disorders · 2004 · 2.3K citations
Medicine, Neurology, Neuroscience +17
J. Parkinson · Journal of Neuropsychiatry · 2002 · 1.6K citations
Medicine, Neurology, Psychiatry +8
Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
Jeffrey H. Kordower, C. Warren Olanow, Hemraj B. Dodiya et al. · Brain · 2013 · 1.3K citations · Full text
Quantitative gait dysfunction and risk of cognitive decline and dementia
Joe Verghese, C. Wang, R.B. Lipton et al. · Journal of Neurology Neurosurgery & Psychiatry · 2007 · 788 citations · Full text